IRIDEX Corporation is an ophthalmic medical technology company. It develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
企業コードIRIX
会社名IRIDEX Corp
上場日Feb 16, 1996
最高経営責任者「CEO」Mr. Patrick Mercer
従業員数93
証券種類Ordinary Share
決算期末Feb 16
本社所在地1212 Terra Bella Ave
都市MOUNTAIN VIEW
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号94043
電話番号16509404700
ウェブサイトhttps://www.iridex.com/
企業コードIRIX
上場日Feb 16, 1996
最高経営責任者「CEO」Mr. Patrick Mercer
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし